Barletta C, Scavo D
Università degli Studi di Roma La Sapienza, I Cattedra di Patologia Speciale Medica e Metodologia Clinica.
Minerva Med. 1990 May;81(5):363-70.
Beta-endorphin (B-Ep), ACTH plasma levels and cortisol serum levels have been evaluated by RIA, in 27 patients suffering from essential blood hypertension and in 20 healthy control subjects. The study was repeated in the hypertensive group after clonidine treatment for 15 days. B-Ep plasma levels were normal in the I stage of hypertension and did not show any significant difference in relation to the severity and duration of hypertension. ACTH and cortisol circulating levels in the hypertensive patients were in normal range. The increase of B-Ep plasma levels in the II and III stage of the hypertension is not modified by the reduction of blood pressure values; therefore it is unlikely linked to the elevated blood pressure, but probably to the vascular complications. Moreover, the results obtained after clonidine treatment seem to exclude that the hypotensive action of the drug is mediated by increment of B-Ep circulating levels.
采用放射免疫分析法(RIA)对27例原发性高血压患者和20名健康对照者的β-内啡肽(B-Ep)、促肾上腺皮质激素(ACTH)血浆水平及皮质醇血清水平进行了评估。在高血压组患者接受可乐定治疗15天后重复该研究。高血压I期患者的B-Ep血浆水平正常,与高血压的严重程度和病程无关,无显著差异。高血压患者的促肾上腺皮质激素(ACTH)和皮质醇循环水平在正常范围内。高血压II期和III期患者B-Ep血浆水平的升高并未因血压值的降低而改变;因此,其不太可能与血压升高有关,而可能与血管并发症有关。此外,可乐定治疗后获得的结果似乎排除了该药物的降压作用是由B-Ep循环水平升高介导的可能性。